Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray

American Academy of Allergy Asthma & Immunology. The allergy report, volume I: overview of allergic diseases: diagnosis, management, and barriers to care. Milwaukee, WI: AAAAI; 2000.

Fireman, 1991, Allergic rhinitis, 9.2

McMenamin, 1994, Costs of hay fever in the United States in 1990, Ann Allergy, 7, 35

Centers for Disease Control and Prevention: National Center for Health Statistics: National Ambulatory Medical Care Survey: 2004 summary. Accessed August 11, 2008, [http://www.cdc.gov/nchs/data/ad/ad374.pdf]

Rossoff, 1997, The health and economic impact of rhinitis, Am J Manag Care, 3, S8

Santos, 1999, Economic outcomes of a targeted intervention program: the costs of treating allergic rhinitis patients, Am J Manag Care, 5, S225

Kay, 2000, The effects of antihistamines on cognition and performance, J Allergy Clin Immunol, 105, S622, 10.1067/mai.2000.106153

The UCB Institute of Allergy: European Allergy White Paper. Chapter 5: Socio-economic costs of allergic diseases. Brussels, Belgium: UCB;1997.

Bousquet, 1994, Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire, J Allergy Clin Immunol, 94, 182, 10.1053/ai.1994.v94.a54939

Thompson, 2000, Quality of life in patients with allergic rhinitis, Ann Allergy Asthma Immunol, 85, 338, 10.1016/S1081-1206(10)62543-4

Malone, 1997, A cost of illness study of allergic rhinitis in the United States, J Allergy Clin Immunol, 99, 22

Spector, 1997, Overview of comorbid associations of allergic rhinitis, J Allergy Clin Immunol, 99, S773, 10.1016/S0091-6749(97)70126-X

Settipane, 1999, Complications of allergic rhinitis, Allergy Asthma Proc, 20, 209, 10.2500/108854199778339053

Meltzer, 2005, A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis, Treat Respir Med, 4, 289, 10.2165/00151829-200504040-00007

Kirmaz, 1999, Sexual dysfunction in patients with allergic rhinoconjunctivitis, Ann Allergy Asthma Immunol, 95, 525, 10.1016/S1081-1206(10)61013-7

Dykewicz, 1998, Executive summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis, Ann Allergy Asthma Immunol, 81, 463, 10.1016/S1081-1206(10)63152-3

Lamb, 2006, Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective, Curr Med Res Opin, 22, 1203, 10.1185/030079906X112552

Bousquet, 2001, ARIAWorkshop Group, World Health Organization. Allergic rhinitis and its impact on asthma, J Allergy Clin Immunol, 108, S147, 10.1067/mai.2001.118891

van Cauwenberge, 2000, Consensus statement on the treatment of allergic rhinitis, Allergy, 55, 116, 10.1034/j.1398-9995.2000.00526.x

Mygind, 1993, Glucocorticosteroids and rhinitis, Allergy, 48, 476, 10.1111/j.1398-9995.1993.tb01103.x

Bachert, 2002, Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis, Ann Allergy Asthma Immunol, 89, 292, 10.1016/S1081-1206(10)61957-6

Storms, 2001, Introduction: patient preference of inhaled nasal corticosteroids, Allergy Asthma Proc, 22, S1

Blaiss, 2001, Efficacy, safety, and patient preference of inhaled nasal corticosteroids: a review of pertinent published data, Allergy Asthma Proc, 22, S5

Stokes, 2004, Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis, Otolaryngol Head Neck Surg, 131, 225, 10.1016/j.otohns.2004.04.011

Khanna, 2005, Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis, Am J Rhinol, 19, 316, 10.1177/194589240501900318

Nasonex (mometasone furoate nasal spray) [prescribing information]. 2005, Kenilworth, NJ: Schering Corporation

Roper Public Affairs & Media Group of NOP World: Impact of nasal congestion among allergic rhinitis sufferers. August 2004

Dupclay, 2002, Assessment of intranasal corticosteroid use in allergic rhinitis: benefits, costs, and patient preferences, Am J Manag Care, 8, S335